Vaccinosis Nosode 4004 63083-4004
Generic: Vaccinosis Nosode
Product NDC
63083-4004- Manufacturer
- Professional Complementary Health Formulas
- Dosage Form
- Liquid
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- August 15, 1984
- Listing Expires
- December 31, 2027
Active Ingredients
| Ingredient | Strength |
|---|---|
| Anguilla Rostrata Blood Serum | 30 [hp_X]/59mL |
| Clostridium Tetani Toxoid Antigen (formaldehyde Inactivated) | 30 [hp_X]/59mL |
| Diphenyltrichloroethane | 30 [hp_X]/59mL |
| Laurtrimonium Bromide | 30 [hp_X]/59mL |
| Mumps Virus | 30 [hp_X]/59mL |
| Oyster Shell Calcium Carbonate, Crude | 6 [hp_X]/59mL |
| Serum, Horse | 30 [hp_X]/59mL |
| Silicon Dioxide | 6 [hp_X]/59mL |
| Thuja Occidentalis Leaf | 6 [hp_X]/59mL |
Drug Class
Inactivated Clostridium Tetani Vaccine [EPC]Actively Acquired Immunity [PE]Inactivated Clostridium Tetani Vaccine [EPC]
Packaging Options(1)
59 mL in 1 BOTTLE, DROPPER (63083-4004-2)